carvedilol has been researched along with vidarabine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Cai, W; Fujita, T; Hidaka, Y; Ishikawa, Y; Kishimura, M; Nakamura, T; Suita, K; Uechi, M; Umemura, M; Yokoyama, U | 1 |
2 other study(ies) available for carvedilol and vidarabine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Vidarabine, an Anti-Herpes Virus Agent, Protects Against the Development of Heart Failure With Relatively Mild Side-Effects on Cardiac Function in a Canine Model of Pacing-Induced Dilated Cardiomyopathy.
Topics: Animals; Antiviral Agents; Carbazoles; Cardiomyopathy, Dilated; Carvedilol; Disease Models, Animal; Dogs; Female; Heart Failure; Herpesviridae; Humans; Propanolamines; Vidarabine | 2016 |